17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
about
The structural biology of oestrogen metabolismA unique co-culture model for fundamental and applied studies of human fetoplacental steroidogenesis and interference by environmental chemicalsHydroxybenzothiazoles as new nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1)Human hydroxysteroid dehydrogenases and pre-receptor regulation: insights into inhibitor design and evaluation.Genome-wide analysis of brain and gonad transcripts reveals changes of key sex reversal-related genes expression and signaling pathways in three stages of Monopterus albusSynergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.Cysteine-10 on 17 β -Hydroxysteroid Dehydrogenase 1 Has Stabilizing Interactions in the Cofactor Binding Region and Renders Sensitivity to Sulfhydryl Modifying Chemicals.Diabetes area participation analysis: a review of companies and targets described in the 2008 - 2010 patent literature.Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage.Recent discovery of plant-derived anti-diabetic natural products.Crucial Role of 3-Bromoethyl in Removing the Estrogenic Activity of 17β-HSD1 Inhibitor 16β-(m-Carbamoylbenzyl)estradiol.Design of a Mestranol 2-N-Piperazino-Substituted Derivative Showing Potent and Selective in vitro and in vivo Activities in MCF-7 Breast Cancer Models.Synthesis of novel 13α-estrone derivatives by Sonogashira coupling as potential 17β-HSD1 inhibitors.Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3).Synthesis and Biological Evaluation of Triazolyl 13α-Estrone-Nucleoside Bioconjugates.Comparative investigation of the in vitro inhibitory potencies of 13-epimeric estrones and D-secoestrones towards 17β-hydroxysteroid dehydrogenase type 1.
P2860
Q27009283-07609CAE-0C2E-4BE9-85CB-E7BB550D2C34Q28383904-705E6525-B822-426B-8DAD-23F875906980Q28478724-A8607632-91E1-4DE0-B3C9-37BA512DE398Q35013689-150FFA7B-6AE2-4052-BFB0-ABA278FBBA2BQ36314907-729BD6EC-2CDD-45D7-A887-D246DFA0F482Q36331426-D9DA4C74-CE09-4EFE-A912-A1F074EDC2BEQ37375199-126E535E-D1FE-41AB-B3D6-33787C6BA893Q37810292-1D5238F3-B28C-4B30-B244-80809D72E7ABQ37989094-9916EAEA-85B4-4A28-BB55-CCCAE491FECFQ38001579-0076B830-D5C7-4605-A347-50029D829F51Q38449142-5A3975CE-F459-4409-BA71-2D8167ACA778Q38722671-D1732CD6-58F6-4B04-9CBF-C5FAD838D694Q40967454-A061C942-B11C-40B7-BE33-2DCBB24E7C80Q42689476-125F8A8A-EF0E-4443-97E3-D3D47BFA3377Q51509301-DBD016B6-621A-4900-B71F-50BFF7800706Q51636762-591E6684-3B1B-480B-9540-251FC2D882D8
P2860
17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
@en
17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
@nl
type
label
17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
@en
17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
@nl
prefLabel
17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
@en
17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
@nl
P2860
P1476
17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
@en
P2093
Donald Poirier
P2860
P304
P356
10.1517/13543776.2010.505604
P407
P577
2010-09-01T00:00:00Z